Related Experiment Video
Updated: Jan 28, 2026

Author Spotlight: A Personalized Approach Towards Investigating Alzheimer's Disease Using an In Vitro Blood-Brain Barrier Model
Published on: October 20, 2023
PANoptosis in urological diseases: molecular mechanisms, pathological roles, and emerging therapeutic opportunities
Xin Di1, Xin Jin2, Shuqiang Feng3
1Department of Respiratory and Critical Care Medicine, The Second Hospital of Jilin University, Changchun, Jilin, China.
Abstract:
PANoptosis, a recently identified inflammatory programmed cell death pathway, integrates features of apoptosis, pyroptosis, and necroptosis and is regulated by a macromolecular complex called the PANoptosome. This pathway extends beyond conventional single-mode death mechanisms, marked a significant advancement in cell death research. Its emerging role in the pathogenesis and progression of urological diseases-including acute and chronic kidney injury, prostate cancer, renal carcinoma, and testicular pathologies-is increasingly recognized. This review outlines the molecular mechanisms and regulatory networks underlying PANoptosis and emphasizes its dual role, both in promoting tissue damage and in driving antitumor immunity. In addition, we discuss novel diagnostic biomarkers and therapeutic strategies targeting key components of PANoptosis, including multi-omics-based biomarker screening, nanomaterial-mediated delivery systems, and combination therapies. Advances in technologies, such as single-cell sequencing and spatial transcriptomics, are expanding precision medicine approaches, positioning PANoptosis as a promising target for improving clinical outcomes in urological diseases.
Insights
PANoptosis, a programmed cell death pathway, integrates apoptosis, pyroptosis, and necroptosis. This pathway is crucial in urological diseases and offers new therapeutic targets for improved patient outcomes.
Area of Science:
- Cell Death Research
- Immunology
- Urology
Background:
- PANoptosis is a novel inflammatory programmed cell death pathway.
- It integrates features of apoptosis, pyroptosis, and necroptosis.
- PANoptosis is regulated by the PANoptosome complex.
Purpose of the Study:
- To review the molecular mechanisms and regulatory networks of PANoptosis.
- To highlight PANoptosis's dual role in tissue damage and antitumor immunity.
- To discuss diagnostic biomarkers and therapeutic strategies for PANoptosis in urological diseases.
Main Methods:
- Literature review of PANoptosis.
- Analysis of PANoptosis's role in urological disease pathogenesis.
- Exploration of multi-omics, nanomaterial delivery, and combination therapies.
Main Results:
- PANoptosis plays a significant role in urological diseases like kidney injury and cancers.
- It exhibits a dual function, causing tissue damage while also stimulating antitumor immunity.
- Novel biomarkers and therapeutic strategies targeting PANoptosis are emerging.
Conclusions:
- PANoptosis is a key pathway in urological diseases.
- Targeting PANoptosis offers potential for novel diagnostics and therapeutics.
- Advances in technology like single-cell sequencing enhance precision medicine for PANoptosis.
Related Concept Videos
Emerging Adulthood
Urologic Endoscopic Procedure: Cystoscopic Examination
Introduction Cardiac Emergencies
Reaction Mechanisms
For instance, the decomposition of ozone appears to follow a mechanism with two steps:
Therapeutic Index
Molecular Models

